| scholarly article | Q13442814 |
| P50 | author | Daniel F. Connor | Q51848525 |
| Geraldine S Pearson | Q56613972 | ||
| P2093 | author name string | Damion J Grasso | |
| Alok Banga | |||
| Michelle D Slivinsky | |||
| P2860 | cites work | Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses | Q24619549 |
| How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. | Q30456148 | ||
| alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data | Q31126424 | ||
| An open trial of citalopram in adolescents with post-traumatic stress disorder | Q31981005 | ||
| Neurotransmitter alterations in PTSD: catecholamines and serotonin | Q33769379 | ||
| Community treatment of posttraumatic stress disorder for children exposed to intimate partner violence: a randomized controlled trial | Q34157290 | ||
| The University of California at Los Angeles Post-traumatic Stress Disorder Reaction Index | Q34308067 | ||
| The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics | Q34421450 | ||
| Clonidine in Cambodian patients with posttraumatic stress disorder | Q34541683 | ||
| Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. | Q34577478 | ||
| Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. | Q34621253 | ||
| A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms | Q34639736 | ||
| Development and natural history of mood disorders | Q34934338 | ||
| Catecholamine influences on dorsolateral prefrontal cortical networks | Q35132548 | ||
| Complex trauma among psychiatrically impaired children: a cross-sectional, chart-review study | Q37539066 | ||
| Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review | Q37742212 | ||
| Achieving remission as a routine goal of pharmacotherapy in attention-deficit hyperactivity disorder | Q37815474 | ||
| Corticolimbic function in impulsive aggressive behavior | Q37870541 | ||
| The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on posttraumatic stress disorder | Q37931993 | ||
| A randomized controlled trial of sertraline to prevent posttraumatic stress disorder in burned children | Q37951103 | ||
| Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders | Q37997168 | ||
| Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial | Q38496484 | ||
| Traumatic events and posttraumatic stress disorder in an urban population of young adults | Q39253925 | ||
| Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial | Q46184315 | ||
| Treating thermally injured children suffering symptoms of acute stress with imipramine and fluoxetine: a randomized, double-blind study | Q46449205 | ||
| A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder | Q46827387 | ||
| Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats | Q48168167 | ||
| Development of the cerebral cortex: XIV. Stress impairs prefrontal cortical function | Q48288251 | ||
| The posttraumatic stress disorder diagnosis in preschool- and elementary school-age children exposed to motor vehicle accidents. | Q51871835 | ||
| The suppression of nightmares with guanfacine | Q71381472 | ||
| Clonidine for posttraumatic stress disorder in preschool children | Q71573724 | ||
| Post-traumatic stress disorder in physically abused adolescents | Q72388512 | ||
| Noradrenergic and serotonergic function in posttraumatic stress disorder | Q73665569 | ||
| New treatments for tic disorders | Q79219456 | ||
| Child abuse and aggression among seriously emotionally disturbed children | Q84061307 | ||
| Violence, abuse, and crime exposure in a national sample of children and youth | Q84634348 | ||
| P433 | issue | 4 | |
| P921 | main subject | teenager | Q1492760 |
| traumatic stress | Q16920843 | ||
| P304 | page(s) | 244-251 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Journal of Child and Adolescent Psychopharmacology | Q15756086 |
| P1476 | title | An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents | |
| P478 | volume | 23 |
| Q57178739 | A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures |
| Q26795806 | Alpha-2 receptor agonists for the treatment of posttraumatic stress disorder |
| Q38225791 | An Update on Posttraumatic Stress Disorder in Children and Adolescents |
| Q26770328 | Animal models for posttraumatic stress disorder: An overview of what is used in research |
| Q35046682 | Chronic Stimulation of Alpha-2A-Adrenoceptors With Guanfacine Protects Rodent Prefrontal Cortex Dendritic Spines and Cognition From the Effects of Chronic Stress |
| Q28083141 | Emerging drugs for the treatment of anxiety |
| Q43176477 | Emotional dysregulation in a child with attention-deficit/hyperactivity disorder and anxiety: psychopharmacological stategies |
| Q36446854 | Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe. |
| Q38225962 | Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents. |
| Q64912439 | Loss of Prefrontal Cortical Higher Cognition with Uncontrollable Stress: Molecular Mechanisms, Changes with Age, and Relevance to Treatment. |
| Q47571614 | Monoamine oxidase A gene methylation and its role in Posttraumatic Stress Disorder - First evidence from the South Eastern Europe (SEE)-PTSD study |
| Q55092559 | Noradrenergic Modulation of Fear Conditioning and Extinction. |
| Q38796437 | Novel pharmacological treatment strategies for posttraumatic stress disorder |
| Q26781227 | Stress weakens prefrontal networks: molecular insults to higher cognition |
| Q28076907 | Targeting Prefrontal Cortical Systems for Drug Development: Potential Therapies for Cognitive Disorders |
| Q34571585 | The Effects of Stress Exposure on Prefrontal Cortex: Translating Basic Research into Successful Treatments for Post-Traumatic Stress Disorder |
| Q42070708 | The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD. |
| Q41880359 | The neurobiology of thought: the groundbreaking discoveries of Patricia Goldman-Rakic 1937-2003. |
| Q33598487 | The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals |
| Q89716254 | Translating molecular and neuroendocrine findings in posttraumatic stress disorder and resilience to novel therapies |
| Q49805840 | Traumatic Brain Injury, Sleep Disorders, and Psychiatric Disorders: An Underrecognized Relationship. |
| Q38654153 | Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review. |
Search more.